First AI-generated small molecule drug enters Phase II trial
Insilico Medicine’s novel AI-generated small molecule inhibitor drug represents a new milestone in pharmaceutical drug development.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed
